Multispectral tissue characterization in a RIF-1 tumor model: Monitoring the ADC and T2 responses to single-dose radiotherapy. Part II

Magnetic Resonance in Medicine

Volumn 57, Issue 3, 2007, Pages 513-519

  Henning, Erica C ^a   Azuma, Chieko ^b   Sotak, Christopher H ^a,c,d   Helmer, Karl G ^a,e  

^a Worcester Polytechnic Institute   (United States)

^b TUFTS UNIVERSITY   (United States)

^c Worcester Polytechnic Institute   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Diffusion; Multispectral analysis; Radiotherapy; RIF 1; Tumor

Indexed keywords

CELL DEATH; DIFFUSION; K-MEANS CLUSTERING; PHYSIOLOGICAL MODELS; RADIOTHERAPY; SURFACE DIFFUSION; TUMORS;

APPARENT DIFFUSION COEFFICIENT; MONITORING THERAPY; MULTI-SPECTRAL ANALYSIS; MULTIPLE COMPARTMENTS; QUANTITATIVE ASSESSMENTS; RADIATION INDUCED FIBROSARCOMA; RIF-1; TISSUE CHARACTERIZATION;

GROWTH KINETICS;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RADIOTHERAPY; CELL DENSITY; CELL KILLING; CONTROLLED STUDY; DIFFUSION COEFFICIENT; FEMALE; FIBROSARCOMA; IMAGE ANALYSIS; MOUSE; NONHUMAN; PATIENT MONITORING; RADIOSENSITIVITY; TISSUE CHARACTERIZATION; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR NECROSIS; TUMOR VOLUME;

EID: 33847734403     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.21178     Document Type: Article

References (27)

1. 1H-NMR spectroscopy in a murine tumor in vivo. Br J Cancer 1996;73:61-64.
2. Galons JP, Altbach MI, Paine-Murrieta GD, Taylor CW, Gillies RJ. Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. Neoplasia 1999;1:113-117.
3. Chinnaiyan AM, Prasad U, Shankar S, Hamstra DA, Shanaiah M, Chenevert TL, Ross BD, Rehemtulla A. Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy. Proc Natl Acad Sci USA 2000;97:1754-1759.
4. Jennings D, Hatton BN, Guo J, Galons JP, Trouard TP, Raghunand N, Marshall J, Gillies RJ. Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI. Neoplasia 2002;4:255-262.
5. Moffat BA, Hall DE, Stohnnovska J, McConville PJ, Moody JB, Chenevert TL, Rehemtulla A, Ross BD. Diffusion imaging for evaluation of tumor therapies in preclinical animal models. MAGMA 2004;17:249-259.
6. Chenevert TL, McKeever PE, Ross BD. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res 1997;3:1457-1466.
7. Chenevert TL, Stegman LD, Taylor JMG, Robertson PL, Greenberg HS, Rehemtulla A, Ross BD. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 2000;92:2029-2036.
8. Dzik-Jurasz A, Domenig C, George M, Wolber J, Padhani A, Brown G, Doran S. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet 2002;360:307-308.
9. Lyng H, Haraldseth O, Rofstad EK. Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn Reson Med 2000;43:828-836.
10. Helmer KG, Meiler MR, Sotak CH, Petruccelli JD. Comparison of the return-to-the-origin probability and the apparent diffusion coefficient of water as indicators of necrosis in RIF-1 tumors. Magn Reson Med 2003;49:468-478.
11. Clark MC, Hall LO, Goldgof DB, Velthuizen R, Murtagh FR, Silbiger MS. Automatic tumor segmentation using knowledge-based techniques. IEEE Trans Med Imaging 1998;17:187-201.
12. Tzika AA, Astrakas LG, Zarifi MK, Petridou N, Young-Poussaint T, Goumnerova L, Zurakowski D, Anthony DC, Black PM. Multiparametric MR assessment of pediatric brain tumors. Neuroradiology 2003;45:1-10.
13. Jacobs MA, Barker PB, Bluemke DA, Maranto C, Arnold C, Herskovits EH, Bhujwalla Z. Benign and malignant breast lesions: diagnosis with multiparametric MR imaging. Radiology 2003;229:225-232.
14. Carano RA, Ross AL, Ross J, Williams SP, Koeppen H, Schwall RH, Bruggen NV. Quantification of tumor tissue populations by multispectral analysis. Magn Reson Med 2004;51:542-551.
15. Mazurchuk R, Glaves D, Raghavan D. Magnetic resonance imaging of response to chemotherapy in orthotopic xenografts of human bladder cancer. Clin Cancer Res 1997;3:1635-1641.
16. Ross BD, Zhao YJ, Neal ER, Ben-Yoseph O, Chenevert TL. Contributions of cell kill and posttreatment tumor growth rates to the repopulation of intracerebral 9L tumors after chemotherapy: an MRI study. Proc Natl Acad Sci USA 1998;95:7012-7017.
17. He Z, Evelhoch JL, Mohammad RM, Adsay NV, Pettit GR, Vaitkevicius VK, Sarkar FH. Magnetic resonance imaging to measure therapeutic response using an orthotopic model of human pancreatic cancer. Pancreas 2000;21:69-76.
18. Stegman LD, Rehemtulla A, Hamstra DA, Rice DJ, Jonas SJ, Stout KL, Chenevert TL, Ross BD. Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy. Gene Ther 2000;7:1005-1010.
19. Ross BD, Chenevert TL, Garwood M, Kim B, Stegman LD, Ben-Yoseph O, Zwolshen J, Rehemtulla A, Sunkara PS. Evaluation of (E)-2′-deoxy-2′- (fluoromethylene)cytidine on the 9L rat brain tumor model using MRI. NMR Biomed 2003;16:67-76.
20. Lazareff JA, Suwinski R, de Rosa R, Olmstead CE. Tumor volume and growth kinetics in hypothalamic-chiasmatic pediatric low grade gliomas. Pediatr Neurosurg 1998;30:312-319.
21. Newman WI, Lazareff JA. A mathematical model for self-limiting brain tumors. J Theor Biol 2003;222:361-371.
22. Henning EC, Azuma C, Sotak CH, Helmer KG. Multispectral tissue characterization in a RIF-1 tumor model with histological validation. Part I. Magn Reson Med 2007;57:501-512.
23. Duda R, Hart P. Pattern classification. New York: John Wiley & Sons: 2001.
24. Steele GG. Growth kinetics of tumors. Oxford: Clarendon; 1977.
25. Hopwood LE, Davies BM, Moulder JE. Drug resistance following irradiation of RIF-1 tumors: influence of the interval between irradiation and drug treatment. Int J Radiat Oncol Biol Phys 1990;19:643-650.
26. Gabalski EC, Adam M, Pinto H, Brown JM, Bloch DA, Terris DJ. Pretreatment and midtreatment measurement of oxygen tension levels in head and neck cancers. Laryngoscope 1998;108:1856-1860.
27. Rofstad EK, Mathiesen B, Galappathi K. Increased metastatic dissemination in human melanoma xenografts after subcurative radiation treatment: radiation-induced increase in fraction of hypoxic cells and hypoxia-induced up-regulation of urokinase-type plasminogen activator receptor. Cancer Res 2004;64:13-18.